Global Swine Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 93
Published Date: 04 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Swine Flu Vaccine market size was valued at USD 1580.5 million in 2023 and is forecast to a readjusted size of USD 2321.5 million by 2030 with a CAGR of 5.6% during review period.
Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Swine Flu Vaccine industry chain, the market status of Hospital Pharmacies (Intradermal Vaccination, Intramuscular Vaccination), Retail Pharmacies (Intradermal Vaccination, Intramuscular Vaccination), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Swine Flu Vaccine.
Regionally, the report analyzes the Swine Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Swine Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Swine Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Swine Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Intradermal Vaccination, Intramuscular Vaccination).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Swine Flu Vaccine market.
Regional Analysis: The report involves examining the Swine Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Swine Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Swine Flu Vaccine:
Company Analysis: Report covers individual Swine Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Swine Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Swine Flu Vaccine. It assesses the current state, advancements, and potential future developments in Swine Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Swine Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Swine Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Clinic And Vaccination Centers
Major players covered
Novartis
CSL Limited
Zydus Cadila
AstraZeneca
GlaxoSmithKline
Sanofi
Baxter
Sinovac Biotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Swine Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Flu Vaccine, with price, sales, revenue and global market share of Swine Flu Vaccine from 2019 to 2024.
Chapter 3, the Swine Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Swine Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Flu Vaccine.
Chapter 14 and 15, to describe Swine Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Swine Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Intradermal Vaccination
1.3.3 Intramuscular Vaccination
1.3.4 Subcutaneous Vaccination
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.4.5 Clinic And Vaccination Centers
1.5 Global Swine Flu Vaccine Market Size & Forecast
1.5.1 Global Swine Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Swine Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Swine Flu Vaccine Average Price (2019-2030)
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Swine Flu Vaccine Product and Services
2.1.4 Novartis Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments/Updates
2.2 CSL Limited
2.2.1 CSL Limited Details
2.2.2 CSL Limited Major Business
2.2.3 CSL Limited Swine Flu Vaccine Product and Services
2.2.4 CSL Limited Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Limited Recent Developments/Updates
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Swine Flu Vaccine Product and Services
2.3.4 Zydus Cadila Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Zydus Cadila Recent Developments/Updates
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Swine Flu Vaccine Product and Services
2.4.4 AstraZeneca Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AstraZeneca Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Swine Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Swine Flu Vaccine Product and Services
2.6.4 Sanofi Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi Recent Developments/Updates
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business
2.7.3 Baxter Swine Flu Vaccine Product and Services
2.7.4 Baxter Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Baxter Recent Developments/Updates
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Swine Flu Vaccine Product and Services
2.8.4 Sinovac Biotech Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Biotech Recent Developments/Updates
3.1 Global Swine Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Swine Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Swine Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Swine Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Swine Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Swine Flu Vaccine Manufacturer Market Share in 2023
3.5 Swine Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Flu Vaccine Market: Region Footprint
3.5.2 Swine Flu Vaccine Market: Company Product Type Footprint
3.5.3 Swine Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Swine Flu Vaccine Market Size by Region
4.1.1 Global Swine Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Swine Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Swine Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Swine Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Swine Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Swine Flu Vaccine Consumption Value (2019-2030)
4.5 South America Swine Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Swine Flu Vaccine Consumption Value (2019-2030)
5.1 Global Swine Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Swine Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Swine Flu Vaccine Average Price by Type (2019-2030)
6.1 Global Swine Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Swine Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Swine Flu Vaccine Average Price by Application (2019-2030)
7.1 North America Swine Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Swine Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Swine Flu Vaccine Market Size by Country
7.3.1 North America Swine Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Swine Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Swine Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Swine Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Swine Flu Vaccine Market Size by Country
8.3.1 Europe Swine Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Swine Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Swine Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Swine Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Swine Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Swine Flu Vaccine Market Size by Country
10.3.1 South America Swine Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Swine Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Swine Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Swine Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Swine Flu Vaccine Market Drivers
12.2 Swine Flu Vaccine Market Restraints
12.3 Swine Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Swine Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Flu Vaccine
13.3 Swine Flu Vaccine Production Process
13.4 Swine Flu Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Flu Vaccine Typical Distributors
14.3 Swine Flu Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Swine Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Swine Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Swine Flu Vaccine Product and Services
Table 6. Novartis Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis Recent Developments/Updates
Table 8. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 9. CSL Limited Major Business
Table 10. CSL Limited Swine Flu Vaccine Product and Services
Table 11. CSL Limited Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Limited Recent Developments/Updates
Table 13. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 14. Zydus Cadila Major Business
Table 15. Zydus Cadila Swine Flu Vaccine Product and Services
Table 16. Zydus Cadila Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Zydus Cadila Recent Developments/Updates
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Swine Flu Vaccine Product and Services
Table 21. AstraZeneca Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. AstraZeneca Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Swine Flu Vaccine Product and Services
Table 26. GlaxoSmithKline Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Swine Flu Vaccine Product and Services
Table 31. Sanofi Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi Recent Developments/Updates
Table 33. Baxter Basic Information, Manufacturing Base and Competitors
Table 34. Baxter Major Business
Table 35. Baxter Swine Flu Vaccine Product and Services
Table 36. Baxter Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Baxter Recent Developments/Updates
Table 38. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Biotech Major Business
Table 40. Sinovac Biotech Swine Flu Vaccine Product and Services
Table 41. Sinovac Biotech Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sinovac Biotech Recent Developments/Updates
Table 43. Global Swine Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 44. Global Swine Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Swine Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 46. Market Position of Manufacturers in Swine Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Swine Flu Vaccine Production Site of Key Manufacturer
Table 48. Swine Flu Vaccine Market: Company Product Type Footprint
Table 49. Swine Flu Vaccine Market: Company Product Application Footprint
Table 50. Swine Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Swine Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Swine Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 53. Global Swine Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 54. Global Swine Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Swine Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Swine Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 57. Global Swine Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 58. Global Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 59. Global Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 60. Global Swine Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Swine Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Swine Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 63. Global Swine Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 64. Global Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 65. Global Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 66. Global Swine Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Swine Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Swine Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 69. Global Swine Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 70. North America Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 71. North America Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 72. North America Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 73. North America Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 74. North America Swine Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 75. North America Swine Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 76. North America Swine Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Swine Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 79. Europe Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 80. Europe Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 81. Europe Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 82. Europe Swine Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 83. Europe Swine Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 84. Europe Swine Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Swine Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 87. Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 88. Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 89. Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 90. Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 91. Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 92. Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 95. South America Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 96. South America Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 97. South America Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 98. South America Swine Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 99. South America Swine Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 100. South America Swine Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Swine Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 103. Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 104. Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 105. Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 106. Middle East & Africa Swine Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 107. Middle East & Africa Swine Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 108. Middle East & Africa Swine Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Swine Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Swine Flu Vaccine Raw Material
Table 111. Key Manufacturers of Swine Flu Vaccine Raw Materials
Table 112. Swine Flu Vaccine Typical Distributors
Table 113. Swine Flu Vaccine Typical Customers
List of Figures
Figure 1. Swine Flu Vaccine Picture
Figure 2. Global Swine Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Swine Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Intradermal Vaccination Examples
Figure 5. Intramuscular Vaccination Examples
Figure 6. Subcutaneous Vaccination Examples
Figure 7. Others Examples
Figure 8. Global Swine Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Swine Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Hospital Pharmacies Examples
Figure 11. Retail Pharmacies Examples
Figure 12. Online Pharmacies Examples
Figure 13. Clinic And Vaccination Centers Examples
Figure 14. Global Swine Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Swine Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Swine Flu Vaccine Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Swine Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 18. Global Swine Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Swine Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Swine Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Swine Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Swine Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Swine Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Swine Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Swine Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Swine Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Swine Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Swine Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Swine Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Swine Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Swine Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 33. Global Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Swine Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Swine Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 36. North America Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Swine Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Swine Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Swine Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Swine Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Swine Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 56. China Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Swine Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Swine Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Swine Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Swine Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Swine Flu Vaccine Market Drivers
Figure 77. Swine Flu Vaccine Market Restraints
Figure 78. Swine Flu Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Swine Flu Vaccine in 2023
Figure 81. Manufacturing Process Analysis of Swine Flu Vaccine
Figure 82. Swine Flu Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis CSL Limited Zydus Cadila AstraZeneca GlaxoSmithKline Sanofi Baxter Sinovac Biotech
Related Reports
01 Apr 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
